Stronger radiotherapy treats prostate cancer in less than three weeks

Shorter courses of radiotherapy for prostate cancer are safe and effective, a study has found, saving patients time and potentially reducing waiting lists. Researchers found that higher doses of “ultra-hypofractionated” radiotherapy every other day for two and a half weeks worked as well as standard radiotherapy given every week day for eight weeks.
The Times

A new collaboration to maximise the benefits of radiation oncology

With the advent of personalised cancer medicine, patients may not always receive the most effective treatment in their particular case. In a bid to put this situation to rights, the European Organisation for the Research and Treatment of Cancer (EORTC) and the European Society for Radiotherapy and Oncology (ESTRO) have joined forces to launch a new initiative, E2-RADIatE (EORTC-ESTRO Radiation Infrastructure for Europe). The project will be presented for the first time at the ESTRO 37 conference.

Leading the fight against children’s brain tumours: Prof Richard Gilbertson on CRUK’s new centre

The new Cancer Research UK Centre of Excellence in Cambridge and London aims to improve treatment and survival rates. Professor Richard Gilbertson is leading the biggest push yet to bring about a major change in survival rates as director of the new Cancer Research UK Children’s Brain Tumour Centre of Excellence at the University of Cambridge and the ICR (Institute for Cancer Research) in London.
Cambridge Independent

MP to chair national roundtable meeting to boost access to radiotherapy

South Lakes MP Tim Farron will chair a national meeting this week to discuss how to improve access to cancer services across the country. Attending the meeting, which takes place in Westminster next Wednesday, will be leading professionals including clinicians, scientists and cancer treatment manufacturers. Tim will be chairing the meeting in his capacity as a patron of the leading cancer charity Action Radiotherapy.